TCG Crossover GP II, LLC - 30 Jan 2026 SCHEDULE 13G Report for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO)

Filing Manager: TCG Crossover GP II, LLC
Reporting Manager: Chen Yu
Security: ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share
Symbol: ALXO
Shares outstanding: 131,432,818 shares
Disclosed Ownership: 13,011,849 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 06 Feb 2026, 16:42:36 UTC
Date of event: 30 Jan 2026
SEC: View on sec.gov

Quoteable Key Fact

"TCG Crossover GP II, LLC disclosed 9.9% ownership in ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO) on 30 Jan 2026."

Quick Takeaways

TCG Crossover GP II, LLC filed SCHEDULE 13G for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO).
Disclosed ownership: 9.9%.
Date of event: 30 Jan 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TCG Crossover GP II, LLC	5%	6,505,925	6,505,925	/s/ Craig Skaling	Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P.	5%	6,505,925	6,505,925	/s/ Craig Skaling	Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC	5%	6,505,924	6,505,924	/s/ Craig Skaling	Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P.	5%	6,505,924	6,505,924	/s/ Craig Skaling	Craig Skaling, Authorized Signatory
Chen Yu	9.9%	13,011,849	13,011,849	/s/ Craig Skaling	Craig Skaling, as Attorney-in-Fact for Chen Yu